{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:30:39Z","timestamp":1793417439218,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11136-026-04398-3","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:58:08Z","timestamp":1790002688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychometric evaluation of PROMIS\u00ae fatigue and cognitive function short forms customized for adults living with primary sclerosing cholangitis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-8714","authenticated-orcid":false,"given":"Bryce B.","family":"Reeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Thorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Gomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Evon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"2","key":"4398_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus, C. L., Arriv\u00e9, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., & Tabibian, J. H. (2023). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology,77(2), 659\u2013702.","journal-title":"Hepatology"},{"issue":"8","key":"4398_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/tri.13925","volume":"34","author":"T Visseren","year":"2021","unstructured":"Visseren, T., Erler, N. S., Polak, W. G., Adam, R., Karam, V., Vondran, F. W. R., Ericzon, B. G., Thorburn, D., Ijzermans, J. N. M., Paul, A., & Van Der Heide, F. (2021). Recurrence of primary sclerosing cholangitis after liver transplantation\u2014analysing the European Liver Transplant Registry and beyond. Transplant International,34(8), 1455\u20131467.","journal-title":"Transplant International"},{"key":"4398_CR3","unstructured":"PSC Partners Seeking a Cure (2022). The voice of the patient: Primary sclerosing cholangitis (PSC): Report of an externally-led patient-focused drug development meeting. PSC-Partners Patient-Focused Drug Development Forum (PFDD). Retrieved https:\/\/pscpartners.org\/resources\/patient-focused-drug-development.html"},{"issue":"7","key":"4398_CR4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","volume":"17","author":"A Kuo","year":"2019","unstructured":"Kuo, A., Gomel, R., Safer, R., Lindor, K. D., Everson, G. T., & Bowlus, C. L. (2019). Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry. Clinical Gastroenterology and Hepatology,17(7), 1372\u20131378.","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"9","key":"4398_CR5","doi-asserted-by":"publisher","first-page":"e01009","DOI":"10.1097\/HC9.0000000000001009","volume":"10","author":"DM Evon","year":"2026","unstructured":"Evon, D. M., Merkler, K., Anderson, C., Deutsch-Link, S., Gomel, R., Hatchett, J., Safer, R., Rossi, S. J., Bowlus, C. L., Swain, M., & Reeve, B. B. (2026). Symptom burden is associated with health-related quality of life in symptomatic adults with primary sclerosing cholangitis. Hepatology Communications,10(9), e01009.","journal-title":"Hepatology Communications"},{"issue":"6","key":"4398_CR6","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s10620-015-4013-1","volume":"61","author":"AC Cheung","year":"2016","unstructured":"Cheung, A. C., Patel, H., Meza-Cardona, J., Cino, M., Sockalingam, S., & Hirschfield, G. M. (2016). Factors that influence health-related quality of life in patients with primary sclerosing cholangitis. Digestive Diseases and Sciences,61(6), 1692\u20131699.","journal-title":"Digestive Diseases and Sciences"},{"key":"4398_CR7","unstructured":"U.S. Food & Drug Adminstration (2024). FDA patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making | FDA. Retrieved https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"issue":"2","key":"4398_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOG.0000000000001075","volume":"41","author":"DM Evon","year":"2025","unstructured":"Evon, D. M., & Reeve, B. B. (2025). Assessing patient-reported outcomes in primary sclerosing cholangitis: An update. Current Opinion in Gastroenterology,41(2), 59\u201366.","journal-title":"Current Opinion in Gastroenterology"},{"issue":"9","key":"4398_CR9","doi-asserted-by":"publisher","first-page":"e70814","DOI":"10.1111\/liv.70814","volume":"46","author":"DM Evon","year":"2026","unstructured":"Evon, D. M., Merkler, K., Mkumba, L., Lucas, N., Wright, L., Hatchett, J., Gomel, R., Smith, P. J., Deutsch-Link, S., Bowlus, C. L., & Swain, M. G. (2026). Fatigue and cognitive impairment in adults with primary sclerosing cholangitis: Results from concept elicitation interviews. Liver International,46(9), e70814.","journal-title":"Liver International"},{"issue":"9","key":"4398_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11136-026-04364-z","volume":"35","author":"DM Evon","year":"2026","unstructured":"Evon, D. M., Mkumba, L., Lucas, N., Lin, L., Wright, L., Merkler, K., Gomel, R. C., Safer, R., Maloney, K., Bowlus, C. L., & Reeve, B. B. (2026). Design and evaluation of PROMIS\u00ae fatigue and cognitive function short forms customized for adults with primary sclerosing cholangitis. Quality of Life Research,35(9), 263.","journal-title":"Quality of Life Research"},{"issue":"12","key":"4398_CR11","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s11136-019-02289-4","volume":"28","author":"M Yang","year":"2019","unstructured":"Yang, M., Keller, S., & Lin, J.-M.S. (2019). Psychometric properties of the PROMIS\u00ae fatigue short form 7a among adults with myalgic encephalomyelitis\/chronic fatigue syndrome. Quality of Life Research,28(12), 3375\u20133384.","journal-title":"Quality of Life Research"},{"issue":"10","key":"4398_CR12","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.apmr.2010.08.033","volume":"92","author":"JS Lai","year":"2011","unstructured":"Lai, J. S., Cella, D., Choi, S., Junghaenel, D. U., Christodoulou, C., Gershon, R., & Stone, A. (2011). How item banks and their application can influence measurement practice in rehabilitation medicine: A PROMIS fatigue item bank example. Archives of Physical Medicine and Rehabilitation,92(10), S20\u2013S27.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"2","key":"4398_CR13","first-page":"255","volume":"58","author":"R Fieo","year":"2016","unstructured":"Fieo, R., Ocepek-Welikson, K., Kleinman, M., Eimicke, J. P., Crane, P. K., Cella, D., & Teresi, J. A. (2016). Measurement equivalence of the patient reported outcomes measurement information System\u00ae (PROMIS\u00ae) applied cognition\u2014Ge neral concerns, short forms in ethnically diverse groups. Psychological Test and Assessment Modeling,58(2), 255\u2013307.","journal-title":"Psychological Test and Assessment Modeling"},{"issue":"1","key":"4398_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7224\/1537-2073.2012-047","volume":"16","author":"H Becker","year":"2014","unstructured":"Becker, H., Stuifbergen, A., Lee, H., & Kullberg, V. (2014). Reliability and validity of PROMIS cognitive abilities and cognitive concerns scales among people with multiple sclerosis. International Journal of MS Care,16(1), 1\u20138.","journal-title":"International Journal of MS Care"},{"key":"4398_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jclinepi.2015.08.038","volume":"73","author":"KF Cook","year":"2016","unstructured":"Cook, K. F., Jensen, S. E., Schalet, B. D., Beaumont, J. L., Amtmann, D., Czajkowski, S., Dewalt, D. A., Fries, J. F., Pilkonis, P. A., Reeve, B. B., & Stone, A. A. (2016). PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. Journal of Clinical Epidemiology,73, 89\u2013102.","journal-title":"Journal of Clinical Epidemiology"},{"key":"4398_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psychres.2016.10.072","volume":"247","author":"M Howland","year":"2017","unstructured":"Howland, M., Tatsuoka, C., Smyth, K. A., & Sajatovic, M. (2017). Evaluating PROMIS(\u00ae) applied cognition items in a sample of older adults at risk for cognitive decline. Psychiatry Research,247, 39\u201342.","journal-title":"Psychiatry Research"},{"issue":"2","key":"4398_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cncr.30354","volume":"123","author":"RE Jensen","year":"2017","unstructured":"Jensen, R. E., Moinpour, C. M., Potosky, A. L., Lobo, T., Hahn, E. A., Hays, R. D., Cella, D., Smith, A. W., Wu, X. C., Keegan, T. H., & Paddock, L. E. (2017). Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort. Cancer,123(2), 327\u2013335.","journal-title":"Cancer"},{"key":"4398_CR18","doi-asserted-by":"publisher","first-page":"104048","DOI":"10.1016\/j.msard.2022.104048","volume":"66","author":"P Kamudoni","year":"2022","unstructured":"Kamudoni, P., Johns, J., Cook, K. F., Salem, R., Salek, S., Raab, J., Middleton, R., Henke, C., & Amtmann, D. (2022). A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires. Multiple Sclerosis and Related Disorders,66, 104048.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"4398_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41687-023-00574-y","volume":"7","author":"CB Terwee","year":"2023","unstructured":"Terwee, C. B., van der Willik, E. M., van Breda, F., van Jaarsveld, B. C., van de Putte, M., Jetten, I. W., Dekker, F. W., Meuleman, Y., & van Ittersum, F. J. (2023). Responsiveness and minimal important change of seven PROMIS computerized adaptive tests (CAT) in patients with advanced chronic kidney disease. Journal of Patient-Reported Outcomes,7(1), 35.","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"5","key":"4398_CR20","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve, B. B., Hays, R. D., Bjorner, J. B., Cook, K. F., Crane, P. K., Teresi, J. A., Thissen, D., Revicki, D. A., Weiss, D. J., Hambleton, R. K., & Liu, H. (2007). Psychometric evaluation and calibration of health-related quality of life item banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Medical Care,45(5), S22\u2013S31.","journal-title":"Medical Care"},{"issue":"11","key":"4398_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jclinepi.2009.11.021","volume":"63","author":"H Liu","year":"2010","unstructured":"Liu, H., Cella, D., Gershon, R., Shen, J., Morales, L. S., Riley, W., & Hays, R. D. (2010). Representativeness of the patient-reported outcomes measurement information system internet panel. Journal of Clinical Epidemiology,63(11), 1169\u20131178.","journal-title":"Journal of Clinical Epidemiology"},{"key":"4398_CR22","volume-title":"Test theory: A unified treatment","author":"RP McDonald","year":"1999","unstructured":"McDonald, R. P. (1999). Test theory: A unified treatment (1st ed.). Psychology Press.","edition":"1"},{"key":"4398_CR23","volume-title":"Principles and practice of structural equation modeling","author":"RB Kline","year":"2016","unstructured":"Kline, R. B. (2016). Principles and practice of structural equation modeling (4th ed.). Guilford Press.","edition":"4"},{"issue":"1","key":"4398_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1999","unstructured":"Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal,6(1), 1\u201355.","journal-title":"Structural Equation Modeling: A Multidisciplinary Journal"},{"issue":"2","key":"4398_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K., & Li, M. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine,15(2), 155\u2013163.","journal-title":"Journal of Chiropractic Medicine"},{"issue":"1","key":"4398_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen, J. (1992). A power primer. Psychological Bulletin,112(1), 155\u2013159.","journal-title":"Psychological Bulletin"},{"key":"4398_CR27","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates.","edition":"2"},{"issue":"2","key":"4398_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/liv.15440","volume":"43","author":"E Wunsch","year":"2023","unstructured":"Wunsch, E., Krause, L., Gevers, T. J., Schramm, C., Janik, M. K., Krawczyk, M., Willemse, J., Uhlenbusch, N., L\u00f6we, B., Lohse, A. W., & Milkiewicz, P. (2023). Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey. Liver International,43(2), 381\u2013392.","journal-title":"Liver International"},{"issue":"9","key":"4398_CR29","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/liv.12775","volume":"35","author":"J Haapam\u00e4ki","year":"2015","unstructured":"Haapam\u00e4ki, J., Tenca, A., Sintonen, H., Barner-Rasmussen, N., & F\u00e4rkkil\u00e4, M. A. (2015). Health-related quality of life among patients with primary sclerosing cholangitis. Liver International,35(9), 2194\u20132201.","journal-title":"Liver International"},{"issue":"1","key":"4398_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12955-021-01739-3","volume":"19","author":"E Marcus","year":"2021","unstructured":"Marcus, E., Stone, P., Krooupa, A.-M., Thorburn, D., & Vivat, B. (2021). Quality of life in primary sclerosing cholangitis: A systematic review. Health and Quality of Life Outcomes,19(1), 100.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"10","key":"4398_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/00365520410003434","volume":"39","author":"E Bj\u00f6rnsson","year":"2004","unstructured":"Bj\u00f6rnsson, E., Simren, M., Olsson, R., & Chapman, R. W. (2004). Fatigue in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology,39(10), 961\u2013968.","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"9","key":"4398_CR32","doi-asserted-by":"publisher","first-page":"e70276","DOI":"10.1111\/liv.70276","volume":"45","author":"C Levy","year":"2025","unstructured":"Levy, C., Younossi, Z. M., Mayo, M. J., Kremer, A. E., Pate, J., Ieyoub, J., Zincavage, R., Padilla, B., Ito, D., & Perez, C. F. M. (2025). Assessment of PBC pruritus from the ITCH-E Study: Quality of life, productivity, and treatment experiences. Liver International,45(9), e70276.","journal-title":"Liver International"},{"issue":"6","key":"4398_CR33","doi-asserted-by":"publisher","first-page":"e0153","DOI":"10.1097\/HC9.0000000000000153","volume":"7","author":"CL Bowlus","year":"2023","unstructured":"Bowlus, C. L., Eksteen, B., Cheung, A. C., Thorburn, D., Moylan, C. A., Pockros, P. J., Forman, L. M., Dorenbaum, A., Hirschfield, G. M., Kennedy, C., & Jaecklin, T. (2023). Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology Communications,7(6), e0153.","journal-title":"Hepatology Communications"},{"issue":"1","key":"4398_CR34","first-page":"5","volume":"6","author":"MM Tana","year":"2018","unstructured":"Tana, M. M., Alao, H., Morris, N., Bernstein, S., Hattenbach, J., Rehman, R. B., Brychta, R., Sarkar, S., Zhao, X., Walter, M., & Buckley, A. (2018). Fatigued patients with chronic liver disease have subtle aberrations of sleep, melatonin and cortisol circadian rhythms. Fatigue: Biomedicine, Health & Behavior,6(1), 5\u201319.","journal-title":"Fatigue: Biomedicine, Health & Behavior"},{"issue":"1","key":"4398_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ajg.2017.240","volume":"113","author":"B Kochar","year":"2018","unstructured":"Kochar, B., Martin, C. F., Kappelman, M. D., Spiegel, B. M., Chen, W., Sandler, R. S., & Long, M. D. (2018). Evaluation of gastrointestinal patient reported outcomes measurement information system (GI-PROMIS) symptom scales in subjects with inflammatory bowel diseases. American Journal of Gastroenterology,113(1), 72\u201379.","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"4398_CR36","doi-asserted-by":"publisher","first-page":"e0196908","DOI":"10.1371\/journal.pone.0196908","volume":"13","author":"DM Evon","year":"2018","unstructured":"Evon, D. M., Stewart, P. W., Amador, J., Serper, M., Lok, A. S., Sterling, R. K., Sarkar, S., Golin, C. E., Reeve, B. B., Nelson, D. R., & Reau, N. (2018). A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS ONE,13(8), e0196908.","journal-title":"PLoS ONE"},{"issue":"1","key":"4398_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41687-019-0105-6","volume":"3","author":"CO Bingham III","year":"2019","unstructured":"Bingham, C. O., III., Gutierrez, A. K., Butanis, A., Bykerk, V. P., Curtis, J. R., Leong, A., Lyddiatt, A., Nowell, W. B., Orbai, A. M., & Bartlett, S. J. (2019). PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. Journal of Patient-Reported Outcomes,3(1), 14.","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"4398_CR38","doi-asserted-by":"publisher","first-page":"690383","DOI":"10.3389\/fnagi.2021.690383","volume":"13","author":"JA Frontera","year":"2021","unstructured":"Frontera, J. A., Lewis, A., Melmed, K., Lin, J., Kondziella, D., Helbok, R., Yaghi, S., Meropol, S., Wisniewski, T., Balcer, L., & Galetta, S. L. (2021). Prevalence and predictors of prolonged cognitive and psychological symptoms following COVID-19 in the United States. Frontiers in Aging Neuroscience,13, 690383.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"4398_CR39","doi-asserted-by":"publisher","first-page":"42595","DOI":"10.1038\/s41598-025-26568-y","volume":"15","author":"KR Staab","year":"2025","unstructured":"Staab, K. R., McIntosh, M. J., Puliyakote, A. S. K., Hahn, A. D., AlArab, N., Percy, J. L., Lanning, T., Theeler, J., Linkenmeyer, C., Wharff, C. J., & Bruening, E. (2025). Long COVID: Lung pathophysiology and its relationship with cognitive dysfunction. Scientific Reports,15(1), 42595.","journal-title":"Scientific Reports"},{"issue":"1","key":"4398_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.psychres.2014.12.043","volume":"226","author":"BY Saffer","year":"2015","unstructured":"Saffer, B. Y., Lanting, S. C., Koehle, M. S., Klonsky, E. D., & Iverson, G. L. (2015). Assessing cognitive impairment using PROMIS<comment>\u00ae<\/comment> applied cognition-abilities scales in a medical outpatient sample. Psychiatry Research,226(1), 169\u2013172.","journal-title":"Psychiatry Research"},{"key":"4398_CR41","unstructured":"HealthMeasures. Healthmeasures. [cited 2026 Jun 4]. Retrieved https:\/\/www.healthmeasures.net\/"},{"key":"4398_CR42","unstructured":"HealthMeasures Scoring Service powered by Assessment CenterSM. HealthMeasures Scoring Service powered by Assessment CenterSM. [cited 2026 Jun 4]. Retrieved https:\/\/www.assessmentcenter.net\/ac_scoringservice"},{"issue":"10","key":"4398_CR43","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s11136-021-02925-y","volume":"30","author":"CB Terwee","year":"2021","unstructured":"Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffiths, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of life Research,30(10), 2729\u20132754.","journal-title":"Quality of life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04398-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:02:29Z","timestamp":1793415749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4398"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04398-3","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"21 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christopher L. Bowlus: Advisory role \u2013 Gilead, Ipsen, Intercept, GSK, Mirum, Cymabay, COUR, Kezar, Astra Zeneca, Esperion, Pliant, Chemomab; Grants \u2013 BMS, Chemomab, COUR, Cymabay, Gilead, GSK, Hanmi, Intercept, Ipsen, Mirum, Novartis, Novo Nordisk, Pliant, Viking, Zydus. Bryce Reeve: Consultant role \u2013 Vertex Pharmaceutical, Daiichi Sankyo Pharmaceutical. All other authors have nothing to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PSC Partners Patient Registry\u2019s consent forms, protocols, and surveys are all reviewed and approved by the North Star Review Board.","order":2,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants of the PSC Partners Patient Registry included in the study.","order":3,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"289"}}